Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study

ConclusionIn a real-world setting, less than 50% continued ALN treatment for 5 years. We found no difference in the risk of fractures in patients discontinuing versus continuing ALN after 5 years.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research